Skip to main content
Erschienen in: Osteoporosis International 12/2016

25.08.2016 | Review

Comparative efficacy of parathyroidectomy and active surveillance in patients with mild primary hyperparathyroidism: a systematic review and meta-analysis

verfasst von: N. Singh Ospina, S. Maraka, R. Rodriguez-Gutierrez, A. E. Espinosa de Ycaza, S. Jasim, M. Gionfriddo, A. Castaneda-Guarderas, J. P. Brito, A. Al Nofal, P. Erwin, R. Wermers, V. Montori

Erschienen in: Osteoporosis International | Ausgabe 12/2016

Einloggen, um Zugang zu erhalten

Abstract

Counseling for patients with primary hyperparathyroidism (PHPT) and mild hypercalcemia without indications for surgical intervention requires accurate estimates of the potential benefits of parathyroidectomy. We aim to summarize the available evidence regarding the benefits of parathyroidectomy that patients with mild PHPT without indications for surgery experience compared to observation. We searched multiple databases from inception to August 2015. We included randomized controlled trials (RCT) and observational studies that evaluated changes in bone health, quality of life or neuropsychiatric symptoms, or in the risk of nephrolithiasis, cardiovascular events, or death between patients undergoing parathyroidectomy or active surveillance. Eight studies were eligible. Risk differences were not significant, in part due to lack of events (fractures, nephrolithiasis, cardiovascular events, or deaths). No significant differences were observed across measures of bone health, quality of life, and neuropsychiatric symptoms. A single RCT evaluating bone mineral density (BMD) changes at 5 years found a small statistically significant effect favoring parathyroidectomy. Patients with mild PHPT without indications for surgery experience a limited number of adverse consequences during short-term follow-up limiting our ability to estimate the benefit of surgery during this timeframe. This information is helpful as these patients consider surgery versus active surveillance. Long-term data is warranted to determine who benefits in the long run from surgical intervention and the extent to which this benefit affects outcomes that matter to patients.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C, Potts JT Jr (2014) Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab 99(10):3561–3569. doi:10.1210/jc.2014-1413 CrossRefPubMed Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C, Potts JT Jr (2014) Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab 99(10):3561–3569. doi:10.​1210/​jc.​2014-1413 CrossRefPubMed
3.
Zurück zum Zitat Sankaran S, Gamble G, Bolland M, Reid IR, Grey A (2010) Skeletal effects of interventions in mild primary hyperparathyroidism: a meta-analysis. J Clin Endocrinol Metab 95(4):1653–1662. doi:10.1210/jc.2009-2384 CrossRefPubMed Sankaran S, Gamble G, Bolland M, Reid IR, Grey A (2010) Skeletal effects of interventions in mild primary hyperparathyroidism: a meta-analysis. J Clin Endocrinol Metab 95(4):1653–1662. doi:10.​1210/​jc.​2009-2384 CrossRefPubMed
4.
Zurück zum Zitat Udelsman R, Akerstrom G, Biagini C, Duh QY, Miccoli P, Niederle B, Tonelli F (2014) The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab 99(10):3595–3606. doi:10.1210/jc.2014-2000 CrossRefPubMed Udelsman R, Akerstrom G, Biagini C, Duh QY, Miccoli P, Niederle B, Tonelli F (2014) The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab 99(10):3595–3606. doi:10.​1210/​jc.​2014-2000 CrossRefPubMed
6.
Zurück zum Zitat Maraka S, Kennel KA (2015) Bisphosphonates for the prevention and treatment of osteoporosis. Bmj-Brit Med J 351. doi:Artn H3783 10.1136/Bmj.H3783 Maraka S, Kennel KA (2015) Bisphosphonates for the prevention and treatment of osteoporosis. Bmj-Brit Med J 351. doi:Artn H3783 10.​1136/​Bmj.​H3783
7.
Zurück zum Zitat Sackett WR, Barraclough B, Reeve TS, Delbridge LW (2002) Worldwide trends in the surgical treatment of primary hyperparathyroidism in the era of minimally invasive parathyroidectomy. Arch Surg 137(9):1055–1059CrossRefPubMed Sackett WR, Barraclough B, Reeve TS, Delbridge LW (2002) Worldwide trends in the surgical treatment of primary hyperparathyroidism in the era of minimally invasive parathyroidectomy. Arch Surg 137(9):1055–1059CrossRefPubMed
8.
Zurück zum Zitat Wermers RA, Khosla S, Atkinson EJ, Achenbach SJ, Oberg AL, Grant CS, Melton LJ 3rd (2006) Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease. J Bone Miner Res 21(1):171–177. doi:10.1359/JBMR.050910 CrossRefPubMed Wermers RA, Khosla S, Atkinson EJ, Achenbach SJ, Oberg AL, Grant CS, Melton LJ 3rd (2006) Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease. J Bone Miner Res 21(1):171–177. doi:10.​1359/​JBMR.​050910 CrossRefPubMed
9.
Zurück zum Zitat Chen H, Wang TS, Yen TW, Doffek K, Krzywda E, Schaefer S, Sippel RS, Wilson SD (2010) Operative failures after parathyroidectomy for hyperparathyroidism: the influence of surgical volume. Ann Surg 252(4):691–695. doi:10.1097/SLA.0b013e3181f698df PubMed Chen H, Wang TS, Yen TW, Doffek K, Krzywda E, Schaefer S, Sippel RS, Wilson SD (2010) Operative failures after parathyroidectomy for hyperparathyroidism: the influence of surgical volume. Ann Surg 252(4):691–695. doi:10.​1097/​SLA.​0b013e3181f698df​ PubMed
11.
Zurück zum Zitat Sejean K, Calmus S, Durand-Zaleski I, Bonnichon P, Thomopoulos P, Cormier C, Legmann P, Richard B, Bertagna XY, Vidal-Trecan GM (2005) Surgery versus medical follow-up in patients with asymptomatic primary hyperparathyroidism: a decision analysis. Eur J Endocrinol 153(6):915–927. doi:10.1530/eje.1.02029 CrossRefPubMed Sejean K, Calmus S, Durand-Zaleski I, Bonnichon P, Thomopoulos P, Cormier C, Legmann P, Richard B, Bertagna XY, Vidal-Trecan GM (2005) Surgery versus medical follow-up in patients with asymptomatic primary hyperparathyroidism: a decision analysis. Eur J Endocrinol 153(6):915–927. doi:10.​1530/​eje.​1.​02029 CrossRefPubMed
13.
Zurück zum Zitat Wermers RACBL (2015) Epidemiology of primary hyperparathyroidism. In: The parathyroids, vol 3 edition. Academic Press, pp 291-308 Wermers RACBL (2015) Epidemiology of primary hyperparathyroidism. In: The parathyroids, vol 3 edition. Academic Press, pp 291-308
14.
Zurück zum Zitat Singh Ospina NM, Rodriguez-Gutierrez R, Maraka S, Espinosa de Ycaza AE, Jasim S, Castaneda-Guarderas A, Gionfriddo MR, Al Nofal A, Brito JP, Erwin P, Richards M, Wermers R, Montori VM (2016) Outcomes of parathyroidectomy in patients with primary hyperparathyroidism: a systematic review and meta-analysis. World J Surg. doi:10.1007/s00268-016-3514-1 PubMed Singh Ospina NM, Rodriguez-Gutierrez R, Maraka S, Espinosa de Ycaza AE, Jasim S, Castaneda-Guarderas A, Gionfriddo MR, Al Nofal A, Brito JP, Erwin P, Richards M, Wermers R, Montori VM (2016) Outcomes of parathyroidectomy in patients with primary hyperparathyroidism: a systematic review and meta-analysis. World J Surg. doi:10.​1007/​s00268-016-3514-1 PubMed
15.
Zurück zum Zitat Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(4):264–269, W264CrossRefPubMed Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(4):264–269, W264CrossRefPubMed
16.
Zurück zum Zitat Guyatt GMV, Devereaux PJ, Schunemann H, Bhandari M (2004) Patients at the center: in our practice, and ir our use of language. ACP J Club 140(1):A11–12PubMed Guyatt GMV, Devereaux PJ, Schunemann H, Bhandari M (2004) Patients at the center: in our practice, and ir our use of language. ACP J Club 140(1):A11–12PubMed
18.
Zurück zum Zitat Wells G SB, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P (2013) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses Wells G SB, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P (2013) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses
19.
Zurück zum Zitat DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188CrossRefPubMed DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188CrossRefPubMed
20.
Zurück zum Zitat McGough JJ, Faraone SV (2009) Estimating the size of treatment effects: moving beyond p values. Psychiatry (Edgmont) 6(10):21–29 McGough JJ, Faraone SV (2009) Estimating the size of treatment effects: moving beyond p values. Psychiatry (Edgmont) 6(10):21–29
22.
Zurück zum Zitat Copenhagen RmRCPV (The Cochrane Collaboration, 2014) Copenhagen RmRCPV (The Cochrane Collaboration, 2014)
23.
Zurück zum Zitat Bollerslev J, Jansson S, Mollerup CL, Nordenstrom J, Lundgren E, Torring O, Varhaug JE, Baranowski M, Aanderud S, Franco C, Freyschuss B, Isaksen GA, Ueland T, Rosen T (2007) Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J Clin Endocrinol Metab 92(5):1687–1692. doi:10.1210/jc.2006-1836 CrossRefPubMed Bollerslev J, Jansson S, Mollerup CL, Nordenstrom J, Lundgren E, Torring O, Varhaug JE, Baranowski M, Aanderud S, Franco C, Freyschuss B, Isaksen GA, Ueland T, Rosen T (2007) Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J Clin Endocrinol Metab 92(5):1687–1692. doi:10.​1210/​jc.​2006-1836 CrossRefPubMed
24.
Zurück zum Zitat Grey AB, Stapleton JP, Evans MC, Reid IR (1996) Accelerated bone loss in post-menopausal women with mild primary hyperparathyroidism. Clin Endocrinol 44(6):697–702CrossRef Grey AB, Stapleton JP, Evans MC, Reid IR (1996) Accelerated bone loss in post-menopausal women with mild primary hyperparathyroidism. Clin Endocrinol 44(6):697–702CrossRef
25.
Zurück zum Zitat Rao DS, Phillips ER, Divine GW, Talpos GB (2004) Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab 89(11):5415–5422. doi:10.1210/jc.2004-0028 CrossRefPubMed Rao DS, Phillips ER, Divine GW, Talpos GB (2004) Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab 89(11):5415–5422. doi:10.​1210/​jc.​2004-0028 CrossRefPubMed
26.
Zurück zum Zitat Rao DS, Wallace EA, Antonelli RF, Talpos GB, Ansari MR, Jacobsen G, Divine GW, Parfitt AM (2003) Forearm bone density in primary hyperparathyroidism: long-term follow-up with and without parathyroidectomy. Clin Endocrinol 58(3):348–354CrossRef Rao DS, Wallace EA, Antonelli RF, Talpos GB, Ansari MR, Jacobsen G, Divine GW, Parfitt AM (2003) Forearm bone density in primary hyperparathyroidism: long-term follow-up with and without parathyroidectomy. Clin Endocrinol 58(3):348–354CrossRef
27.
Zurück zum Zitat Lundstam K, Heck A, Mollerup C, Godang K, Baranowski M, Pernow Y, Varhaug JE, Hessman O, Rosen T, Nordenstrom J, Jansson S, Hellstrom M, Bollerslev J (2015) Effects of parathyroidectomy versus observation on the development of vertebral fractures in mild primary hyperparathyroidism. J Clin Endocrinol Metab 100(4):1359–1367. doi:10.1210/jc.2014-3441 CrossRefPubMed Lundstam K, Heck A, Mollerup C, Godang K, Baranowski M, Pernow Y, Varhaug JE, Hessman O, Rosen T, Nordenstrom J, Jansson S, Hellstrom M, Bollerslev J (2015) Effects of parathyroidectomy versus observation on the development of vertebral fractures in mild primary hyperparathyroidism. J Clin Endocrinol Metab 100(4):1359–1367. doi:10.​1210/​jc.​2014-3441 CrossRefPubMed
28.
Zurück zum Zitat Edwards ME, Rotramel A, Beyer T, Gaffud MJ, Djuricin G, Loviscek K, Solorzano CC, Prinz RA (2006) Improvement in the health-related quality-of-life symptoms of hyperparathyroidism is durable on long-term follow-up. Surgery 140(4):655–663. doi:10.1016/j.surg.2006.06.016, discussion 653-654CrossRefPubMed Edwards ME, Rotramel A, Beyer T, Gaffud MJ, Djuricin G, Loviscek K, Solorzano CC, Prinz RA (2006) Improvement in the health-related quality-of-life symptoms of hyperparathyroidism is durable on long-term follow-up. Surgery 140(4):655–663. doi:10.​1016/​j.​surg.​2006.​06.​016, discussion 653-654CrossRefPubMed
29.
Zurück zum Zitat Okamoto T, Kamo T, Obara T (2002) Outcome study of psychological distress and nonspecific symptoms in patients with mild primary hyperparathyroidism. Arch Surg 137(7):779–783, discussion 784CrossRefPubMed Okamoto T, Kamo T, Obara T (2002) Outcome study of psychological distress and nonspecific symptoms in patients with mild primary hyperparathyroidism. Arch Surg 137(7):779–783, discussion 784CrossRefPubMed
30.
Zurück zum Zitat Perrier ND, Balachandran D, Wefel JS, Jimenez C, Busaidy N, Morris GS, Dong W, Jackson E, Weaver S, Gantela S, Evans DB, Grubbs EG, Lee JE (2009) Prospective, randomized, controlled trial of parathyroidectomy versus observation in patients with “asymptomatic” primary hyperparathyroidism. Surgery 146(6):1116–1122. doi:10.1016/j.surg.2009.09.034 CrossRefPubMed Perrier ND, Balachandran D, Wefel JS, Jimenez C, Busaidy N, Morris GS, Dong W, Jackson E, Weaver S, Gantela S, Evans DB, Grubbs EG, Lee JE (2009) Prospective, randomized, controlled trial of parathyroidectomy versus observation in patients with “asymptomatic” primary hyperparathyroidism. Surgery 146(6):1116–1122. doi:10.​1016/​j.​surg.​2009.​09.​034 CrossRefPubMed
31.
Zurück zum Zitat Tremollieres FA, Pouilles JM, Drewniak N, Laparra J, Ribot CA, Dargent-Molina P (2010) Fracture risk prediction using BMD and clinical risk factors in early postmenopausal women: sensitivity of the WHO FRAX Tool. J Bone Miner Res 25(5):1002–1009. doi:10.1002/jbmr.12 CrossRefPubMedPubMedCentral Tremollieres FA, Pouilles JM, Drewniak N, Laparra J, Ribot CA, Dargent-Molina P (2010) Fracture risk prediction using BMD and clinical risk factors in early postmenopausal women: sensitivity of the WHO FRAX Tool. J Bone Miner Res 25(5):1002–1009. doi:10.​1002/​jbmr.​12 CrossRefPubMedPubMedCentral
32.
33.
34.
Zurück zum Zitat Garratt AM, Ruta DA, Abdalla MI, Buckingham JK, Russell IT (1993) The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS? BMJ 306(6890):1440–1444CrossRefPubMedPubMedCentral Garratt AM, Ruta DA, Abdalla MI, Buckingham JK, Russell IT (1993) The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS? BMJ 306(6890):1440–1444CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Jenkinson C, Coulter A, Wright L (1993) Short form 36 (SF36) health survey questionnaire: normative data for adults of working age. BMJ 306(6890):1437–1440CrossRefPubMedPubMedCentral Jenkinson C, Coulter A, Wright L (1993) Short form 36 (SF36) health survey questionnaire: normative data for adults of working age. BMJ 306(6890):1437–1440CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Goldberg DP, Gater R, Sartorius N, Ustun TB, Piccinelli M, Gureje O, Rutter C (1997) The validity of two versions of the GHQ in the WHO study of mental illness in general health care. Psychol Med 27(1):191–197CrossRefPubMed Goldberg DP, Gater R, Sartorius N, Ustun TB, Piccinelli M, Gureje O, Rutter C (1997) The validity of two versions of the GHQ in the WHO study of mental illness in general health care. Psychol Med 27(1):191–197CrossRefPubMed
41.
Zurück zum Zitat Almqvist EG, Becker C, Bondeson AG, Bondeson L, Svensson J (2004) Early parathyroidectomy increases bone mineral density in patients with mild primary hyperparathyroidism: a prospective and randomized study. Surgery 136(6):1281–1288. doi:10.1016/j.surg.2004.06.059 CrossRefPubMed Almqvist EG, Becker C, Bondeson AG, Bondeson L, Svensson J (2004) Early parathyroidectomy increases bone mineral density in patients with mild primary hyperparathyroidism: a prospective and randomized study. Surgery 136(6):1281–1288. doi:10.​1016/​j.​surg.​2004.​06.​059 CrossRefPubMed
42.
Zurück zum Zitat Nakaoka D, Sugimoto T, Kobayashi T, Yamaguchi T, Kobayashi A, Chihara K (2000) Prediction of bone mass change after parathyroidectomy in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 85(5):1901–1907. doi:10.1210/jcem.85.5.6604 PubMed Nakaoka D, Sugimoto T, Kobayashi T, Yamaguchi T, Kobayashi A, Chihara K (2000) Prediction of bone mass change after parathyroidectomy in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 85(5):1901–1907. doi:10.​1210/​jcem.​85.​5.​6604 PubMed
44.
Zurück zum Zitat Yeh MW, Zhou H, Adams AL, Ituarte PH, Li N, Liu IA, Haigh PI (2016) The relationship of parathyroidectomy and bisphosphonates with fracture risk in primary hyperparathyroidism: an observational study. Ann Intern Med. doi:10.7326/M15-1232 PubMed Yeh MW, Zhou H, Adams AL, Ituarte PH, Li N, Liu IA, Haigh PI (2016) The relationship of parathyroidectomy and bisphosphonates with fracture risk in primary hyperparathyroidism: an observational study. Ann Intern Med. doi:10.​7326/​M15-1232 PubMed
46.
Zurück zum Zitat Ambrogini E, Cetani F, Cianferotti L, Vignali E, Banti C, Viccica G, Oppo A, Miccoli P, Berti P, Bilezikian JP, Pinchera A, Marcocci C (2007) Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J Clin Endocrinol Metab 92(8):3114–3121. doi:10.1210/jc.2007-0219 CrossRefPubMed Ambrogini E, Cetani F, Cianferotti L, Vignali E, Banti C, Viccica G, Oppo A, Miccoli P, Berti P, Bilezikian JP, Pinchera A, Marcocci C (2007) Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J Clin Endocrinol Metab 92(8):3114–3121. doi:10.​1210/​jc.​2007-0219 CrossRefPubMed
47.
Zurück zum Zitat Okamoto T, Gerstein HC, Obara T (1997) Psychiatric symptoms, bone density and non-specific symptoms in patients with mild hypercalcemia due to primary hyperparathyroidism: a systematic overview of the literature. Endocr J 44(3):367–374CrossRefPubMed Okamoto T, Gerstein HC, Obara T (1997) Psychiatric symptoms, bone density and non-specific symptoms in patients with mild hypercalcemia due to primary hyperparathyroidism: a systematic overview of the literature. Endocr J 44(3):367–374CrossRefPubMed
49.
Zurück zum Zitat Rodriguez-Gutierrez R, Gionfriddo MR, Ospina NS, Maraka S, Tamhane S, Montori VM, Brito JP (2016) Shared decision making in endocrinology: present and future directions. Lancet Diabetes Endocrinol. doi:10.1016/S2213-8587(15)00468-4 PubMed Rodriguez-Gutierrez R, Gionfriddo MR, Ospina NS, Maraka S, Tamhane S, Montori VM, Brito JP (2016) Shared decision making in endocrinology: present and future directions. Lancet Diabetes Endocrinol. doi:10.​1016/​S2213-8587(15)00468-4 PubMed
Metadaten
Titel
Comparative efficacy of parathyroidectomy and active surveillance in patients with mild primary hyperparathyroidism: a systematic review and meta-analysis
verfasst von
N. Singh Ospina
S. Maraka
R. Rodriguez-Gutierrez
A. E. Espinosa de Ycaza
S. Jasim
M. Gionfriddo
A. Castaneda-Guarderas
J. P. Brito
A. Al Nofal
P. Erwin
R. Wermers
V. Montori
Publikationsdatum
25.08.2016
Verlag
Springer London
Erschienen in
Osteoporosis International / Ausgabe 12/2016
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-016-3715-3

Weitere Artikel der Ausgabe 12/2016

Osteoporosis International 12/2016 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Knie-TEP: Kein Vorteil durch antibiotikahaltigen Knochenzement

29.05.2024 Periprothetische Infektionen Nachrichten

Zur Zementierung einer Knie-TEP wird in Deutschland zu über 98% Knochenzement verwendet, der mit einem Antibiotikum beladen ist. Ob er wirklich besser ist als Zement ohne Antibiotikum, kann laut Registerdaten bezweifelt werden.

Häusliche Gewalt in der orthopädischen Notaufnahme oft nicht erkannt

28.05.2024 Häusliche Gewalt Nachrichten

In der Notaufnahme wird die Chance, Opfer von häuslicher Gewalt zu identifizieren, von Orthopäden und Orthopädinnen offenbar zu wenig genutzt. Darauf deuten die Ergebnisse einer Fragebogenstudie an der Sahlgrenska-Universität in Schweden hin.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.